These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30888488)

  • 1. Non-invasive assessment of glioma microstructure using VERDICT MRI: correlation with histology.
    Zaccagna F; Riemer F; Priest AN; McLean MA; Allinson K; Grist JT; Dragos C; Matys T; Gillard JH; Watts C; Price SJ; Graves MJ; Gallagher FA
    Eur Radiol; 2019 Oct; 29(10):5559-5566. PubMed ID: 30888488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive diffusion magnetic resonance imaging of brain tumour cell size for the early detection of therapeutic response.
    Roberts TA; Hyare H; Agliardi G; Hipwell B; d'Esposito A; Ianus A; Breen-Norris JO; Ramasawmy R; Taylor V; Atkinson D; Punwani S; Lythgoe MF; Siow B; Brandner S; Rees J; Panagiotaki E; Alexander DC; Walker-Samuel S
    Sci Rep; 2020 Jun; 10(1):9223. PubMed ID: 32514049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microstructural characterization of normal and malignant human prostate tissue with vascular, extracellular, and restricted diffusion for cytometry in tumours magnetic resonance imaging.
    Panagiotaki E; Chan RW; Dikaios N; Ahmed HU; O'Callaghan J; Freeman A; Atkinson D; Punwani S; Hawkes DJ; Alexander DC
    Invest Radiol; 2015 Apr; 50(4):218-27. PubMed ID: 25426656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Brain Tumour Characterisation with VERDICT-MRI: Evaluation of Cellular and Vascular Measures Validated by Histology.
    Figini M; Castellano A; Bailo M; Callea M; Cadioli M; Bouyagoub S; Palombo M; Pieri V; Mortini P; Falini A; Alexander DC; Cercignani M; Panagiotaki E
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voxel-based clustered imaging by multiparameter diffusion tensor images for glioma grading.
    Inano R; Oishi N; Kunieda T; Arakawa Y; Yamao Y; Shibata S; Kikuchi T; Fukuyama H; Miyamoto S
    Neuroimage Clin; 2014; 5():396-407. PubMed ID: 25180159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas.
    Arevalo-Perez J; Peck KK; Young RJ; Holodny AI; Karimi S; Lyo JK
    J Neuroimaging; 2015; 25(5):792-8. PubMed ID: 25867683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.
    Johnston EW; Bonet-Carne E; Ferizi U; Yvernault B; Pye H; Patel D; Clemente J; Piga W; Heavey S; Sidhu HS; Giganti F; O'Callaghan J; Brizmohun Appayya M; Grey A; Saborowska A; Ourselin S; Hawkes D; Moore CM; Emberton M; Ahmed HU; Whitaker H; Rodriguez-Justo M; Freeman A; Atkinson D; Alexander D; Panagiotaki E; Punwani S
    Radiology; 2019 May; 291(2):391-397. PubMed ID: 30938627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis.
    Thust SC; Hassanein S; Bisdas S; Rees JH; Hyare H; Maynard JA; Brandner S; Tur C; Jäger HR; Yousry TA; Mancini L
    Eur Radiol; 2018 Sep; 28(9):3779-3788. PubMed ID: 29572636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
    Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y
    J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of high-grade from low-grade diffuse gliomas using diffusion-weighted imaging: a comparative study of mono-, bi-, and stretched-exponential diffusion models.
    Kusunoki M; Kikuchi K; Togao O; Yamashita K; Momosaka D; Kikuchi Y; Kuga D; Hata N; Mizoguchi M; Iihara K; Suzuki SO; Iwaki T; Akamine Y; Hiwatashi A
    Neuroradiology; 2020 Jul; 62(7):815-823. PubMed ID: 32424712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of diffuse glioma grade and proliferation activity by different diffusion-weighted-imaging models including diffusion kurtosis imaging (DKI) and mean apparent propagator (MAP) MRI.
    Xie SH; Lang R; Li B; Zhao H; Wang P; He JL; Ma XY; Wu Q; Wang SY; Zhang HP; Gao Y; Wu JL
    Neuroradiology; 2023 Jan; 65(1):55-64. PubMed ID: 35835879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravoxel incoherent motion diffusion-weighted imaging analysis of diffusion and microperfusion in grading gliomas and comparison with arterial spin labeling for evaluation of tumor perfusion.
    Shen N; Zhao L; Jiang J; Jiang R; Su C; Zhang S; Tang X; Zhu W
    J Magn Reson Imaging; 2016 Sep; 44(3):620-32. PubMed ID: 26880230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
    Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
    Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.
    Choi HS; Kim AH; Ahn SS; Shin NY; Kim J; Lee SK
    Korean J Radiol; 2013; 14(3):487-92. PubMed ID: 23690718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of high-resolution susceptibility-weighted imaging and the apparent diffusion coefficient: added value to brain tumour imaging and clinical feasibility of non-contrast MRI at 3 T.
    Park SM; Kim HS; Jahng GH; Ryu CW; Kim SY
    Br J Radiol; 2010 Jun; 83(990):466-75. PubMed ID: 19690076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quartile histogram assessment of glioma malignancy using high b-value diffusion MRI with a continuous-time random-walk model.
    Karaman MM; Zhang J; Xie KL; Zhu W; Zhou XJ
    NMR Biomed; 2021 Apr; 34(4):e4485. PubMed ID: 33543512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic role of apparent diffusion coefficient combined with intratumoral susceptibility signals in differentiating high-grade gliomas from brain metastases.
    Bozdağ M; Er A; Çinkooğlu A; Ekmekçi S
    Neuroradiol J; 2021 Jun; 34(3):169-179. PubMed ID: 33307971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of human glioma sphere xenografts in mouse brain using diffusion MRI at 14.1 T.
    Porcari P; Hegi ME; Lei H; Hamou MF; Vassallo I; Capuani S; Gruetter R; Mlynarik V
    NMR Biomed; 2016 Nov; 29(11):1577-1589. PubMed ID: 27717037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.